MM & Co have had plenty of time & money to design and conduct...

MM & Co have had plenty of time & money to design and conduct trials to prove BIT225s worth with conclusive evidence. Unfortunately we are left with much uncertainty and many unanswered questions after a plethora of trials. Big Pharma will only do a deal with absolute conclusive evidence. This is what MM's sole responsibility was, to provide this evidence... she failed. BIT225 will either die or form the basis of next generational drug which will require a lot of $$, stronger management and many more trials.

BIT 225 has been an "interesting" drug for the board to play around with and buy time riding gravy train while CRO's fumbled their way through the work. Test it on this test it on that... raise money for this raise money for that... cup of tea here knitted scarf there.. nothing more than "interesting" results. It's typical scientific fumbling with no clear path to commercialisation as the leaders here simply haven't got a clue. The agreement with C14 consulting group tells us that they are lost at sea with no captain.